Fatty acid amide hydrolase inhibitors. 3: Tetra-substituted azetidine ureas with in vivo activity Article

Roughley, Stephen D, Browne, Helen, Macias, Alba T et al. (2012). Fatty acid amide hydrolase inhibitors. 3: Tetra-substituted azetidine ureas with in vivo activity . BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 22(2), 901-906. 10.1016/j.bmcl.2011.12.032

cited authors

  • Roughley, Stephen D; Browne, Helen; Macias, Alba T; Benwell, Karen; Brooks, Teresa; D'Alessandro, Jalanie; Daniels, Zoe; Dugdale, Sarah; Francis, Geraint; Gibbons, Ben; Hart, Terance; Haymes, Timothy; Kennett, Guy; Lightowler, Sean; Matassova, Natalia; Mansell, Howard; Merrett, Angela; Misra, Anil; Padfield, Anthony; Parsons, Rachel; Pratt, Robert; Robertson, Alan; Simmonite, Heather; Tan, Kiri; Walls, Steven B; Wong, Melanie

sustainable development goals

authors

publication date

  • January 15, 2012

keywords

  • Anandamide
  • Azetidine
  • Cannabinoid signalling
  • Chemistry
  • Chemistry, Medicinal
  • Chemistry, Organic
  • DISCOVERY
  • ENZYME
  • FAAH
  • Fatty acid amide hydrolase (FAAH) inhibitor
  • HYDROLYSIS
  • Life Sciences & Biomedicine
  • PAIN
  • Pharmacology & Pharmacy
  • Physical Sciences
  • SPIROCYCLIC INHIBITORS
  • Science & Technology
  • Urea

Digital Object Identifier (DOI)

publisher

  • PERGAMON-ELSEVIER SCIENCE LTD

start page

  • 901

end page

  • 906

volume

  • 22

issue

  • 2